What is it about?
Our work demonstrates that among colistin-treated patients, those with serum albumin <2.5 g/dl have a 2-fold risk of developing acute kidney injury. These results comes from the analysis of a cohort or patients with bloodstream infections (n=170) who received colistin.
Featured Image
Photo by julien Tromeur on Unsplash
Why is it important?
Pay attention to the development of acute kidney injury in colistin-treated patients with low albumin levels
Read the Original
This page is a summary of: Hypoalbuminemia as a predictor of acute kidney injury during colistin treatment, Scientific Reports, August 2018, Springer Science + Business Media,
DOI: 10.1038/s41598-018-30361-5.
You can read the full text:
Contributors
The following have contributed to this page
